Cheng Cheng ML ML Lee Lee JK JK Kumar Kumar R R Response to MEK Inhibitor Therapy in MAP2K1 (MEK1) K57N Non-Small-Cell Lung Cancer and Genomic Landscape of MAP2K1 Mutations in Non-Small-Cell Lung Cancer Response to MEK Inhibitor Therapy in MAP2K1 (MEK1) K57N Non-Small-Cell Lung Cancer and Genomic Landscape of MAP2K1 Mutations in Non-Small-Cell Lung Cancer Jco Precis Oncol Jco Precis Oncol 2022 2022 6 6 e2200382 e2200382 10.1200/PO.22.00382 10.1200/PO.22.00382 supplied-pmid 36455195? Here, MAP2K1 is linked to non-small cell lung carcinoma.